Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2002-9-6
pubmed:abstractText
Since the introduction of TS-1 for the treatment of gastric carcinoma, an overall high response rate of cancer to TS-1 therapy has been recognized. Therefore, TS-1 in combination with cisplatin (CDDP) can be reasonably expected to be an effective new strategy for the treatment of advanced gastric carcinoma. We administered three courses of the TS-1/CDDP combination in a case of gastric carcinoma with metastasis in a paraaortic lymph node. Regression of the primary carcinoma (72.7% decrease in tumor mass) and reduction in size of the lymph node were observed. Consequently, the patient underwent total gastrectomy, resection of the splenic arterial trunk, splenectomy and D3 lymph node dissection, which resulted in grade B curability. The state of the patient was favorable both at the time of surgery and postoperatively, and the course of therapy remained uneventful. Although grade 1 nausea and vomiting were noted as adverse reactions to the treatment resulting in insufficient oral intake and necessitating intravenous infusion in the hospital, the treatment was completed without any other adverse events during the course of the therapy.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0385-0684
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1427-30
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[A case of gastric carcinoma with metastasis in a paraaortic lymph node that responded to TS-1/CDDP combination therapy, in which the patient was able to undergo extirpation with grade B curability].
pubmed:affiliation
Dept. of Surgery, Saiseikai Suita Hospital.
pubmed:publicationType
Journal Article, English Abstract, Case Reports